Thursday, July 9, 2026

pharma · Amyotrophic Lateral Sclerosis (ALS) · COYA

Coya Therapeutics

Coya Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Paris, FR HQ
2014 Founded
50 Employees
Public company Type
COYA · NYSE Ticker
Company details
Status
Public
HQ
Paris, FR
Founded
2014
Employees
50
Programs
1
Drugs
0
Patents
0
Intelligence · Drug Pipeline

Coya Therapeutics pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Coya Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →